Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung CancerG. Frasci, Mario De Lena, Vito Lorusso et al.|Journal of Clinical Oncology|2000Cited by 452
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patientsAnnamaria Ruzzo, Mauro Magnani, Francesco Graziano et al.|British Journal of Cancer|2017Cited by 68
Cisplatin, Gemcitabine, and Paclitaxel in Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: A Phase I-II StudyG. Frasci, Giuseppe Comella, Nicola Panza et al.|Journal of Clinical Oncology|1999Cited by 54
Feasibility of Sequential Therapy with FOLFIRI Followed by Docetaxel/Cisplatin in Patients with Radically Resected Gastric AdenocarcinomaMaria Di Bartolomeo, Emilio Bajetta, Antonio Ardizzoia et al.|Oncology|2006Cited by 14
Gemcitabine P lus V inorelbine V ersus V inorelbine A lone i n Elderly P atients W ith A dvanced N on-Small-Cell Lung C ancerG. Frasci, Mario De Lena, Vito Lorusso et al.|Unknown|2000Cited by 0